Ralliant (NYSE:RAL) Reaches New 12-Month High Following Better-Than-Expected Earnings

Posted by on May 12th, 2026

Ralliant Corporation (NYSE:RAL – Get Free Report) reached a new 52-week high during trading on Tuesday following a stronger than expected earnings report. The stock traded as high as $60.14 and last traded at $56.7890, with a volume of 1357745 shares traded. The stock had previously closed at $49.56.

The company reported $0.57 EPS for the quarter, beating analysts’ consensus estimates of $0.49 by $0.08. The firm had revenue of $534.60 million for the quarter. Ralliant’s revenue for the quarter was up 11.0% compared to the same quarter last year. Ralliant has set its FY 2026 guidance at 2.530-2.690 EPS and its Q2 2026 guidance at 0.580-0.640 EPS.

Ralliant Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, June 23rd. Stockholders of record on Monday, June 8th will be given a $0.05 dividend. This represents a $0.20 annualized dividend and a dividend yield of 0.4%. The ex-dividend date of this dividend is Monday, June 8th. Ralliant’s payout ratio is currently 10.20%.

Analysts Set New Price Targets

RAL has been the topic of several recent research reports. Barclays decreased their price target on shares of Ralliant from $60.00 to $52.00 and set an “overweight” rating on the stock in a research report on Monday, February 9th. Citigroup decreased their price objective on Ralliant from $61.00 to $51.00 and set a “buy” rating on the stock in a report on Friday, February 6th. Weiss Ratings reissued a “sell (d)” rating on shares of Ralliant in a research note on Monday, May 4th. Vertical Research upgraded shares of Ralliant from a “hold” rating to a “buy” rating and set a $45.00 target price for the company in a report on Friday, February 6th. Finally, Zacks Research raised shares of Ralliant from a “strong sell” rating to a “hold” rating in a research report on Monday, April 13th. Seven equities research analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, Ralliant currently has a consensus rating of “Moderate Buy” and an average price target of $50.50.

Read Our Latest Analysis on RAL

Insider Transactions at Ralliant

In other Ralliant news, SVP Karen M. Bick sold 5,485 shares of the company’s stock in a transaction on Tuesday, March 3rd. The shares were sold at an average price of $45.00, for a total value of $246,825.00. Following the sale, the senior vice president directly owned 46,756 shares of the company’s stock, valued at approximately $2,104,020. This represents a 10.50% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

Hedge Funds Weigh In On Ralliant

Institutional investors and hedge funds have recently modified their holdings of the stock. Vanguard Group Inc. boosted its stake in shares of Ralliant by 10.7% in the third quarter. Vanguard Group Inc. now owns 14,589,423 shares of the company’s stock worth $637,995,000 after buying an additional 1,415,327 shares during the last quarter. Dodge & Cox boosted its position in Ralliant by 13.3% in the 4th quarter. Dodge & Cox now owns 12,214,679 shares of the company’s stock worth $621,849,000 after purchasing an additional 1,434,376 shares in the last quarter. Viking Global Investors LP acquired a new stake in shares of Ralliant during the 2nd quarter worth approximately $257,200,000. Millennium Management LLC grew its stake in shares of Ralliant by 172.4% during the 4th quarter. Millennium Management LLC now owns 4,973,001 shares of the company’s stock worth $253,175,000 after purchasing an additional 3,147,660 shares during the period. Finally, State Street Corp acquired a new position in shares of Ralliant in the 2nd quarter valued at $213,096,000.

Ralliant Price Performance

The stock has a market capitalization of $6.39 billion and a PE ratio of 29.08. The company has a debt-to-equity ratio of 0.38, a current ratio of 0.84 and a quick ratio of 0.58. The stock’s fifty day moving average is $44.32 and its 200-day moving average is $47.07.

Ralliant Company Profile

(Get Free Report)

Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.

Featured Stories

Receive News & Ratings for Ralliant Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ralliant and related companies with MarketBeat.com's FREE daily email newsletter.